Skip to main content

An observational cohort study on terminal cancer survivors practicing falun gong (FLG) in China.

Abstract

e21568
Background: In China, cancer patients may choose to practice FLG -- the most popular Qigong since 1992 -- after treatment failure, arousing great interest in the medical society. Methods: We collected reports from Chinese cancer patients between 2000 and 2015 via a web platform, including diagnosis, FLG practice duration, Actual Survival (AS) till report date, symptom improvement, and Quality of Life (QoL). All reports were reviewed by 2 physicians. Predicted Survival (PS) was assessed using the NIH SEER data if the treating physician’s Clinical Prediction of Survival (CPS) was unavailable. Reports of terminal cancer patients (PS ≤ 12 months) with sufficient and verifiable medical information were considered eligible. Symptom Free Survival (SFS) was also calculated. Results: In the web database, using the search terms "late-stage" and “cancer", we found 406 prospective cases, wherein 152 terminal cases (PS ≤ 12 months) were deemed eligible. Primary cancer types included lung (n = 38), liver (n = 29), stomach (n = 17), leukemia (n = 12), esophagus (n = 10), gynecological (n = 9), pancreas/bile duct (n = 8), colorectal (n = 7), and others (n = 22). The onset age was 53.3±15.6 years. Among them, 65 patients experienced cancer treatment failure, 74 patients did not take any further cancer treatment after diagnosis, and 13 patients received treatment along with FLG practice. The FLG practice duration was 53.1±58.9 months. As of the report date, 149 patients were still alive. Compared with PS (5.1±2.7 months), AS was significantly prolonged to 56.0±60.1 months (P < 0.0001). CPS (5.1±2.0 months) was close to SEER survival (5.2±3.2 months), indicating the reliability of CPS and these reports. Time to Effect was 1.3±1.7 months. A total of 147 patients (96.7%) reported complete symptom recovery with 60 patients confirmed by treating physicians. Time to Symptom Recovery was 3.6±3.3 months, and SFS was 52.7±61.1 months. QoL after FLG practice significantly improved (all Ps < 0.0001). Multivariate analysis showed FLG practice duration was the dominating predictive factor for AS and SFS. Conclusions: We observed that FLG practice can help terminal cancer patients survive significantly longer, in addition to notable symptom improvement.

Information & Authors

Information

Published In

Journal of Clinical Oncology
Pages: e21568

History

Published online: May 20, 2016
Published in print: May 20, 2016

Permissions

Request permissions for this article.

Authors

Affiliations

Yuhong Dong
Novartis, Basel, Switzerland;
Chian-Feng Huang
Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan;
Jim Liao
Gillings School of Public Health, University of North Carolina, Chapel Hill, NC;
Alex Chih-Yu Chen
Imperial College London, London, United Kingdom;
Jason G. Liu
Mind-Body Science Institute, South Pasadena, CA;
Kai-Hsiung Hsu
National Ilan University, Ilan, Taiwan;
Novartis, Basel, Switzerland; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan; Gillings School of Public Health, University of North Carolina, Chapel Hill, NC; Imperial College London, London, United Kingdom; Mind-Body Science Institute, South Pasadena, CA; National Ilan University, Ilan, Taiwan

Notes

Metrics & Citations

Metrics

Altmetric

Citations

Article Citation

Download Citation

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Yuhong Dong, Chian-Feng Huang, Jim Liao, Alex Chih-Yu Chen, Jason G. Liu, Kai-Hsiung Hsu
Journal of Clinical Oncology 2016 34:15_suppl, e21568-e21568

View Options

View options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login

Purchase Options

Purchase this article to get full access to it.

Purchase this Article

Subscribe

Subscribe to this Journal
Renew Your Subscription
Become a Member

Media

Figures

Other

Tables

Share

Share

Share article link

Share